蛋白质稳定网络是急性髓性白血病的治疗目标
Kentson Lam1, Yoon Joon Kim1, Evelyn Li-Ting Tan1
1UC San Diego, La Jolla, California, United States.
Blood
|October 20, 2025
概括
急性髓性白血病 (AML) 细胞通过通过HSF1和自性维持蛋白质平衡 (蛋白质平衡) 来抵抗蛋白质酶抑制剂. 针对这些途径,以及蛋白酶体抑制剂,为AML提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 癌细胞依赖蛋白质平衡 (蛋白质平衡) 才能生存,这使得蛋白质平衡途径成为有吸引力的治疗点.
- 蛋白质酶抑制剂在多发性骨髓瘤中有效,但由于未知的原因,在急性骨髓性白血病 (AML) 中基本上无效.
- 了解AML对蛋白酶体抑制剂的抵抗机制对于开发有效治疗非常重要.
研究的目的:
- 调查为什么蛋白酶体抑制剂在AML中无效.
- 探索针对AML中的蛋白质稳定路径的治疗策略.
- 确定AML中耐药性的关键机制.
主要方法:
- 在蛋白质酶抑制后研究AML细胞中的蛋白质稳定机制.
- 利用HSF1的遗传失活化和联合自和蛋白质酶抑制.
- 对蛋白质合成,增殖,亡和体内疾病进展的评估影响.
- 分析了初级患者AML细胞与正常造血干细胞/原始细胞的反应.
主要成果:
- AML细胞激活HSF1并增加自流量以维持对抗蛋白酶体抑制剂的蛋白质稳定性.
- HSF1的遗传失活化使AML细胞对蛋白酶体抑制产生敏感性,减少增殖并延长存活时间.
- 联合自和蛋白酶体抑制协同杀死AML细胞,优先准AML干细胞/原始细胞.
- 这种组合疗法会诱导由蛋白激酶R (PKR) 驱动的终端综合应激反应.
结论:
- AML细胞选择蛋白质稳定路径 (HSF1,自) 进行生长,进展和耐药性.
- 通过结合自和蛋白质酶抑制来破坏蛋白质稳定网络是AML的一个有希望的治疗策略.
- 这种方法显示,与正常细胞相比,针对AML细胞,包括干细胞/原始细胞种群的疗效优于正常细胞.
相关概念视频
02:26Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
02:18The Proteasome
10.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.1K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
02:58Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K